Pohla H, Adibzadeh M, Bühring H J, Siegels-Hübenthal P, Deikeler T, Owsianowsky M, Schenk A, Rehbein A, Schlotz E, Schaudt K
Medical and Natural Sciences Research Center, University of Tübingen, Federal Republic of Germany.
Dev Immunol. 1993;3(3):197-210. doi: 10.1155/1993/59852.
In order to study extrathymic differentiation in vitro, CD7+CD3- lymphocytes were sorted from normal human bone marrow and cultured under conditions of limiting dilution together with irradiated pooled allogeneic peripheral blood mononuclear cells (PBMC) and phytohemagglutinin (PHA) in the presence of 1000 U/ml of interleukin-2 (IL-2). One clone was obtained that failed to react with monoclonal antibody (mAb) TCR delta 1 (TCR1, gamma/delta-specific) or WT31 (TCR2, alpha/beta-specific). From day 35 through day 74 in culture, the surface phenotype of this clone evolved into CD3+, CD4+, CD8-, TCR2+, TCR1-, and was further characterized as CD2+, CD45RO+, CD16-, and CD56-. The presence of mRNA for TCR alpha and beta but not gamma and delta chains was confirmed by Northern blotting. Accessory cell-dependent autocrine proliferative responses to PHA (most likely driven by IL-2) were initially absent, but became measurable at the same time as the TCR was acquired. However, in the absence of PHA, the clone failed to respond to a panel of homozygous B-cell lines representing the majority of MHC class II alleles. Autoreactivity was also not demonstrable. Cytotoxicity was limited to MHC unrestricted "natural killer (NK)-like" lysis of K562 target cells, with no autocytotoxicity detected. The NK-like lysis diminished over time in parallel with the acquisition of surface TCR. The cloned cells were not suppressive for mature lymphocyte proliferation. After stimulation, the cells secreted tumor necrosis factor alpha and granulocyte/macrophage colony-stimulating factor (GM-CSF) detected by immunoassays, and T-cell growth factors, most likely IL-2, as detected by bioassays. Polymerase chain-reaction methods demonstrated the presence of mRNA for IL-2, IL-3, IL-4, IL-9, interferon-gamma, and GM-CSF in these cells after stimulation with PHA and B-LCL. These results suggest that cells with the phenotype and some functional characteristics of mature T lymphocytes can evolve extrathymically in vitro from T-cell precursors sorted from normal human bone marrow.
为了研究体外胸腺外分化,从正常人骨髓中分离出CD7 + CD3 - 淋巴细胞,并在有限稀释条件下与经辐照的混合异体外周血单个核细胞(PBMC)和植物血凝素(PHA)一起培养,同时存在1000 U/ml的白细胞介素-2(IL-2)。获得了一个克隆,该克隆不与单克隆抗体(mAb)TCRδ1(TCR1,γ/δ特异性)或WT31(TCR2,α/β特异性)反应。在培养的第35天至第74天,该克隆的表面表型演变为CD3 +、CD4 +、CD8 -、TCR2 +、TCR1 -,并进一步表征为CD2 +、CD45RO +、CD16 - 和CD56 -。通过Northern印迹证实存在TCRα和β链的mRNA,但不存在γ和δ链的mRNA。最初不存在对PHA的辅助细胞依赖性自分泌增殖反应(最可能由IL-2驱动),但在获得TCR的同时变得可测量。然而,在没有PHA的情况下,该克隆对一组代表大多数MHC II类等位基因的纯合B细胞系无反应。自身反应性也未得到证实。细胞毒性仅限于对K562靶细胞的MHC非限制性“自然杀伤(NK)样”裂解,未检测到自身细胞毒性。随着表面TCR获得,NK样裂解随时间减少。克隆细胞对成熟淋巴细胞增殖无抑制作用。刺激后,通过免疫测定检测到细胞分泌肿瘤坏死因子α和粒细胞/巨噬细胞集落刺激因子(GM-CSF),通过生物测定检测到细胞分泌T细胞生长因子,最可能是IL-2。聚合酶链反应方法证明,在用PHA和B-LCL刺激后,这些细胞中存在IL-2、IL-3、IL-4、IL-9、干扰素-γ和GM-CSF的mRNA。这些结果表明,具有成熟T淋巴细胞表型和一些功能特征的细胞可以在体外从正常人骨髓中分离的T细胞前体胸腺外分化而来。